Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - March 2013

Controlled Release

18 Mar 2013 - 19 Mar 2013 - London, UK

Bookmark and Share

SMi presents its 10th annual conference on . . .

Controlled Release – the only conference in Europe to focus specifically on controlled release.

At this well-established annual event you will hear, from the global expert speaking faculty, how controlled release products and drugs have developed over the past 12 months.  


• Discover the very latest developments in this innovative and booming industry

• New for 2013:

- Investigating structure-activity relationships of siRNA nanoparticles

- Challenges of pre-clinical gastro-retentive dosage form development

- Numerous case studies from big pharma laboratories – such as GSKs formulation development programme

• Benefit from an interactive half-day post-conference workshop on SMART formulation design: tools and strategies for complex formulation design and problem solving


Michael Keller, PDU Parenteral, Topical & siRNA Lead, Novartis

Andy Lewis, Director, Ipsen

Petra Wicklandt, CMC Development, Merck

Howard Stevens, Professor, Exploratory Drug Discovery, University of Strathclyde

David Elder, Externalisation Director, GlaxoSmithKline

Monica Rosa, Director, SigmoidPharma

Navnit Shah, Distinguished Scientist, Roche

Mark Wilson, Director, Collaboration Management, GlaxoSmithKline

Dmitry Samarsky, Technology & Business Development, Ribobio

Richard Elkes, Senior Research Scientist, Merck 

and many more . . .

Click here for the programme, full speaker line-up and to register 

Further information
Scientific News
Fixing Holes in the Heart Without Invasive Surgery
UV-light enabled catheter is a medical device which represents a major shift in how cardiac defects are repaired.
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
Study Removes Cancer Doubt for Multiple Sclerosis Drug
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.
Antibody Treatment Efficacious in Psoriasis
An experimental, biologic treatment, brodalumab, achieved 100 percent reduction in psoriasis symptoms in twice as many patients as a second, commonly used treatment, according to the results of a multicenter clinical trial led by Mount Sinai researchers.
Scientists Test New Gene Therapy for Vision Loss from a Mitochondrial Disease
NIH-funded study shows success in targeting mitochondrial DNA in mice.
HIV Patients Should Be Included in Early Clinical Trials of Anti-TB Drugs
Tuberculosis is the number one cause of death in HIV-infected patients in Africa and a leading cause of death in this population worldwide.
Multi-Gene Test Enables Some Breast Cancer Patients to Safely Avoid Chemotherapy
A major study is providing the best evidence to date that a 21-gene test done on the tumor can identify breast cancer patients who can safely avoid chemotherapy.
Low Dose Beta-Blockers As Effective As High Dose After a Heart Attack?
Heart attack patients live as long – or even longer – on one-quarter the suggested dose.
Antidepressants Plus Blood-Thinners Slow Down Brain Cancer
EPFL scientists have found that combining antidepressants with anticoagulants slows down brain tumors (gliomas) in mice.
Old Drug Performs New Tricks
Cambridge-led research reveals the powers of a "wonder drug" that has lain under the noses of doctors for 50 years.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos